This report by IDPC analyses the factors that permitted a novel Latin American position to be forged within UNASUR, the main agreements, and lays out the differences of opinion, as well as the drug policy challenges that lie ahead for the region.
Em editorial lançado na semana passada, a importante publicação científica do Reino Unido defendeu o fim da guerra às drogas e conclamou a comunidade médica para a construção de uma nova política, pautada no cuidado e no respeito à dignidade dos usuários.
The EMCDDA publishes a report providing an update on infectious diseases related to injecting drug use in Europe, it covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area.
IDPC outlines the road to the Political Declaration review in 2019, detailing how best to capitalise on progress made at UNGASS and where work still remains to be done.
The Human Rights Awareness and Promotion Forum examines the human rights and public health implications of the new, heavily criminal justice-focused law in Uganda.
Strategic action at the policy level is urgently needed to increase access to HCV prevention, testing and treatment among PWID, the group at highest risk of HCV infection.
These guidelines are designed to improve the quality and consistency of data collected at the country level, enhancing the accuracy of conclusions drawn at national, regional and global levels.
The British Medical Journal argues that evidence and ethics should inform policies that promote health and respect dignity, issue-areas which doctors and their leaders should champion.
The Guide applies a gender perspective to drug policy for Colombia, exploring the differentiated impact of imprisonment and suggesting recommendations for change.
EHRN describes the implementation of its 2014–2015 "Small Grants Program Through Peers’ Effort" in nine countries of Central and Eastern Europe and Central Asia.
